Newstral
Article
Ccontracostatimes.com on 2015-07-07 21:30
Horizon Pharma makes hostile $3B bid for Newark's Depomed
Related news
- Horizon Pharma pushing forward with hostile takeover of DepomedChicago Tribune
- Horizon Pharma makes hostile, $2.1B bid for Depomedjournalrecord.com
- Horizon Pharma raises bid for Depomed to $33 per shareabc3340.com
- CBiotechnology company Horizon to sue East Bay's Depomed in hostile bidcontracostatimes.com
- Horizon Pharma raises offer for DepomedThe Salt Lake Tribune
- Horizon takes hostile Depomed bid directly to shareholdersabqjournal.com
- Horizon pushes hostile Depomed bid with shareholder offerdothaneagle.com
- CHorizon Pharma raises bid for East Bay drugmaker Depomedcontracostatimes.com
- Horizon Pharma makes hostile bid for DepomedThe Salt Lake Tribune
- Horizon Pharma Withdraws Bid for Depomedwsj.com
- Horizon Pharma raises CEO's pay to $93.4MThe Salt Lake Tribune
- MHorizon drops bid for Depomed after legal setbackmarketwatch.com
- Lake Forest-based Horizon Pharma raises CEO Walbert's pay 10-fold to $93.4 millionChicago Tribune
- Horizon drops hostile bid for Depomed after judge’s rulingwkrg.com